Health
Novo Nordisk Launches Wegovy® in Hong Kong for Weight Management
Leading global healthcare company Novo Nordisk announces the launch of Wegovy® in Hong Kong, now available at private clinics and selected pharmacies. Clinically proven for long-term weight management, Wegovy® represents a significant step forward in addressing the city's escalating health burden through evidence-based care for obesity as a chronic disease.
About this update from Novo Nordisk A/s Class B
[{"type":"list","items":[{"val":[{"type":"text","content":"Wegovy® (semaglutide) is a once-weekly injectable prescription medicine used in combination with a reduced calorie diet and increased physical activity for adults and adolescents aged 12 years old or above with obesity or adults with overweight in the presence of at least one related health condition.","length":302,"tagName":"p"}]},{"val":[{"type":"text","content":"In Hong Kong, with over 30% of adults classified as obese[1] and 20% of adolescents being overweight or obese[2], Wegovy® offers an effective treatment option to help combat the rising health burden.","length":199,"tagName":"p"}]},{"val":[{"type":"text","content":"The launch of Wegovy® in Hong Kong extends Novo Nordisk's commitment to addressing obesity as a chronic disease through clinically proven treatments.","length":153,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":654,"olType":false},{"type":"text","content":"HONG KONG, Nov. 3, 2025 /PRNewswire/ -- Leading global healthcare company Novo Nordisk announces the launch of Wegovy® in Hong Kong, now available at private clinics and selected pharmacies. Clinically proven for long-term weight management, Wegovy® represents a significant step forward in addressing the city's escalating health burden through evidence-based care for obesity as a chronic disease.","length":413,"tagName":"p"},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":250,"url":"https://media.zenfs.com/en/prnewswire.com/31ce0f77fdb020d2ac2cef050861a70c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/J3aqG27TFtxmmVSIFA_phg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQ0MTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/31ce0f77fdb020d2ac2cef050861a70c","width":400,"height":250}},"href":"https://mma.prnewswire.com/media/2810055/image_964286_13480542.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Wegovy® is a once-weekly injectable prescription medication used as an adjunct to a reduced calorie diet and increased physical activity for effective long-term weight management. Wegovy® is indicated for[3]:","length":208,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Adults with BMI ≥30 kg/m², or","length":29,"tagName":"p"}]},{"val":[{"type":"...